Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

The Responsible Use of Minimally Invasive Surgery in Remote Areas of Brazil: Feasibility and Safety of a Temporary Gynecologic Operative Expedition
Favero, Giovanni , Carvalho, Luiz Fernando Pina, Barbosa, Thaisa Silveira , Macerox, Nathalia, Barbosa, Priscila Almeida , Pfiffer, Tatiana, Kho, R C., Baracat, Edmund Chada , Project, Bandeira Científica, Abrão, Maurício Simões , Valente, Cristina

Journal of Gynecologic Surgery | July 20, 2015 | Volume: 31 | Issue: 5 | Pages: 255-259

10.1089/gyn.2014.0141 Get It

Demographic and clinical variables affecting mid‐ to late‐life trajectories of plasma ceramide and dihydroceramide species
Mielke, Michelle M. , Bandaru, Veera Venkata Ratnam, Han, Dingfen, An, Yang , Resnick, Susan M. , Ferrucci, Luigi , Haughey, Norman J. , Mielke, Michelle M , Ferrucci, Luigi

Aging Cell | July 20, 2015 | Volume: 14 | Issue: 6 | Pages: 1014-1023

10.1111/acel.12369 | PMID 26193443 Get It

SummaryIt has been increasingly recognized at the basic science level that perturbations in ceramide metabolism are associated with the development and progression of many age‐related diseases. However, the translation of this work to the clinic has lagged behind. Understanding the factors longitudinally associated with plasma ceramides and dihydroceramides (DHCer) at the population level and how these lipid levels change with age, and by sex, is important for the clinical development of future therapeutics and biomarkers focused on ceramide metabolism. We, therefore, examined factors cross‐sectionally and longitudinally associated with plasma concentrations of ceramides and DHCer among Baltimore Longitudinal Study of Aging participants (n = 992; 3960 total samples), aged 55 years and older, with plasma at a mean of 4.1 visits (range 2–6). Quantitative analyses were performed on a high‐performance liquid chromatography‐coupled electrospray ionization tandem mass spectrometer. Linear mixed models were used to assess the relationships between plasma ceramide and DHCer species and demographics, diseases, medications, and lifestyle factors. Women had higher plasma concentrations of most ceramide and DHCer species and showed steeper trajectories of age‐related increases compared to men. Ceramides and DHCer were more associated with waist–hip ratio than body mass index. Plasma cholesterol and triglycerides, prediabetes, and diabetes were associated with ceramides and DHCer, but the relationship showed specificity to the acyl chain length and saturation. These results demonstrate the importance of examining the individual species of ceramides and DHCer, and of establishing whether intra‐individual age‐ and sex‐specific changes occur in synchrony to disease onset and progression.
Chromosomes at Work: Organization of Chromosome Territories in the Interphase Nucleus
Fritz, Andrew J. , Martin‐Buley, Lori A., Wijnen, André J. van , Zaidi, Sayyed K. , Imbalzano, Anthony N. , Lian, Jane B. , Stein, Janet L. , van Wijnen, Andre J, Barutcu, A. Rasim , Stein, Gary S. , van Wijnen, Andre J

Journal of Cellular Biochemistry | July 20, 2015 | Volume: 117 | Issue: 1 | Pages: 9-19

10.1002/jcb.25280 | PMID 26192137 Get It

ABSTRACTThe organization of interphase chromosomes in chromosome territories (CTs) was first proposed more than one hundred years ago. The introduction of increasingly sophisticated microscopic and molecular techniques, now provide complementary strategies for studying CTs in greater depth than ever before. Here we provide an overview of these strategies and how they are being used to elucidate CT interactions and the role of these dynamically regulated, nuclear‐structure building blocks in directly supporting nuclear function in a physiologically responsive manner. J. Cell. Biochem. 117: 9–19, 2016. © 2015 Wiley Periodicals, Inc.
Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B
Kim, W. Ray , Gross, John B. , Stadheim, Linda, Poterucha, John J., Stadheim, Linda M, Wi, Chung‐Il

Gut and Liver | July 20, 2015 | Volume: 10 | Issue: 4 | Pages: 611-616

10.5009/gnl14256 | PMID 26190580 Get It

micro RNA changes in liver tissue associated with fibrosis progression in patients with hepatitis C
Keuren‐Jensen, Kendall Van , Malenica, Ivana , Courtright, Amanda L., Ghaffari, Layla , Starr, Alexander , Metpally, Raghu , Beecroft, Taylor , Carlson, Elizabeth, Kiefer, Jeffrey , Pockros, Paul J. , Rakela, Jorge , Courtright-Lim, Amanda , Van Keuren-Jensen, Kendall R

Liver International | July 20, 2015 | Volume: 36 | Issue: 3 | Pages: 334-343

10.1111/liv.12919 | PMID 26189820 Get It

Abstract Background & Aims Accumulating evidence indicates that micro RNA s play a role in a number of disease processes including the pathogenesis of liver fibrosis in hepatitis C infection. Our goal is to add to the accruing information regarding micro RNA deregulation in liver fibrosis to increase our understanding of the underlying mechanisms of pathology and progression. Methods We used next generation sequencing to profile all detectable micro RNA s in liver tissue and serum from patients with hepatitis C, stages F1–F4 of fibrosis. Results We found altered expression of several micro RNA s, in particular, miR‐182, miR199a‐5p, miR‐200a‐5p and miR‐183 were found to be significantly upregulated in tissue from liver biopsies of hepatitis C patients with advanced fibrosis, stage F3 and F4, when compared with liver biopsies from patients with early fibrosis, stages F1 and F2. We also found miR‐148‐5p, miR‐1260b, miR‐122‐3p and miR‐378i among the micro RNA s most significantly down‐regulated from early to advanced fibrosis of the liver. We also sequenced the serum micro RNA s; however, we were not able to detect significant changes in circulating micro RNA s associated with fibrosis stage after adjusting for multiple tests. Conclusions Adding measurements of tissue micro RNA s acquired during routine biopsies will continue to increase our knowledge of underlying mechanisms of fibrosis. Our goal is that these data, in combination with studies from other researchers and future long‐term studies, could be used to enhance the staging accuracy of liver biopsies and expand the surveillance of patients at increased risk for cancer and progression to advanced fibrosis.
Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapy
Lee, Richard J. , Tzou, Katherine S., Hobbs, C., Rawal, Bhupendra, Diehl, Nancy N. , Peterson, Jennifer , Paryani, Nitesh N., Daugherty, Larry C., Vallow, Laura A., Wong, William W. , Pisansky, Thomas M. , Buskirk, Steven J., Hobbs, Corey J, Peterson, Jennifer L., Ko, Stephen J. , Wong, William, Schild, Steven, Heckman, Michael G. , Schild, Steven E.

BJU International | July 18, 2015 | Volume: 118 | Issue: 2 | Pages: 236-242

10.1111/bju.13229 | PMID 26190356 Get It

Objective To update a previously proposed prognostic scoring system that predicts risk of biochemical recurrence ( BCR ) after salvage radiation therapy ( SRT ) for recurrent prostate cancer when using additional patients and a PSA value of 0.2 ng/ mL and rising as the definition of BCR . Patients and Methods We included 577 patients who received SRT for a rising PSA after radical prostatectomy in this retrospective cohort study. Clinical, pathological, and SRT characteristics were evaluated for association with BCR using relative risks ( RR s) from multivariable Cox regression models. Results With a median follow‐up of 5.5 years after SRT , 354 patients (61%) experienced BCR . At 5 years after SRT , 40% of patients were free of BCR . Independent associations with BCR were identified for the PSA level before SRT ( RR [doubling]: 1.25, P < 0.001), pathological tumour stage ( RR [T3a vs T2] 1.21, P = 0.19; RR [T3b/T4 vs T2] 2.09, P < 0.001; overall P < 0.001), Gleason score ( RR [7 vs <7] 1.63, P < 0.001; RR [8–10 vs <7] 2.28, P < 0.001; overall P < 0.001), and surgical margin status ( RR [positive vs negative] 0.71, P = 0.003). We combined these four variables to create a prognostic scoring system that predicted BCR risk with a c ‐index of 0.66. Scores ranged from 0 to 7, and 5‐year freedom from BCR for different levels of the score was as follows: Score = 0–1: 66%, Score = 2: 46%, Score = 3: 28%, Score = 4: 19%, and Score = 5–7: 15%. Conclusion We developed a scoring system that provides an estimation of the risk of BCR after SRT . These findings will be useful for patients and physicians in decision making for radiation therapy in the salvage setting.
Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta‐analysis
Singh, Siddharth , Khera, Rohan , Murad, M. Hassan , Loomba, Rohit , Allen, Alina M. , Murad, M Hassan , Loomba, Rohit , Khera, Rohan

Hepatology | July 18, 2015 | Volume: 62 | Issue: 5 | Pages: 1417-1432

10.1002/hep.27999 | PMID 26189925 Get It

We performed a Bayesian network meta‐analysis combining direct and indirect treatment comparisons to assess the comparative effectiveness of pharmacological agents for the treatment of nonalcoholic steatohepatitis (NASH). Through systematic literature review, we identified nine randomized, controlled trials (RCTs) including 964 patients with biopsy‐proven NASH, comparing vitamin E, thiazolidinediones (TZDs), pentoxifylline, or obeticholic acid to one another or placebo. The primary outcome was improvement in fibrosis stage; secondary outcomes were improvement in ballooning degeneration, lobular inflammation, and steatosis. We reported relative risks (RRs) and 95% confidence intervals (CIs) from direct meta‐analysis and 95% credible intervals (CrIs) from Bayesian network meta‐analysis, and used Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria to appraise quality of evidence. Moderate‐quality evidence supports the use of pentoxifylline (RR, 0.26; 95% CrI: 0.05‐1.00) and obeticholic acid (RR, 0.81; 95% CI: 0.70‐0.95) over placebo in improving fibrosis. High‐quality evidence supports the effect of vitamin E, TZDs, and obeticholic acid over placebo in improving ballooning degeneration. All four interventions seemed to have at least moderate‐quality evidence over placebo to improve steatosis. Moderate‐quality evidence supports that TZDs, pentoxifylline, and obeticholic acid decrease lobular inflammation. All the head‐to‐head comparisons were supported by very‐low‐quality evidence except for superiority of TZDs over vitamin E on improving steatosis and lobular inflammation, which had moderate‐quality evidence. Conclusions : Based on direct and network meta‐analysis, pentoxifylline and obeticholic acid improve fibrosis, and vitamin E, TZDs, and obeticholic acid improve ballooning degeneration in patients with NASH. Future comparative trials of combination therapies targeting distinct histological features are warranted. (H epatology 2015;62:1417–1432)
Sleep, death, and the heart
Mansukhani, Meghna P. , Wang, Shihan , Somers, Virend K. , Mansukhani, Meghna P

American Journal of Physiology-Heart and Circulatory Physiology | July 18, 2015 | Volume: 309 | Issue: 5 | Pages: H739-H749

10.1152/ajpheart.00285.2015 | PMID 26188022 Get It

Obstructive and central sleep apnea have been associated with increased risk of adverse cardiovascular events and mortality. Sympathetic dysregulation occurring as a result of the respiratory disturbance is thought to play a role in this increased risk. Sleep apnea increases the risk of arrhythmias, myocardial ischemia/infarction, stroke, and heart failure, all of which may increase mortality risk. A higher incidence of nocturnal arrhythmias, cardiac ischemia, and sudden death has been noted in subjects with sleep-disordered breathing (SDB). In this review, the association between SDB and each of these conditions is discussed, as well as the potential mechanisms underlying these risks and the effects of treatment of SDB. Particular emphasis is placed on the relationship between SDB and nocturnal atrial and ventricular arrhythmias, myocardial ischemia/infarction and sudden death.
Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)
Mahoney, Michelle R., Yoon, Harry H. , Smyrk, Thomas C. , Thibodeau, Stephen N. , Goldberg, Richard M. , Nelson, Garth D. , Sinicrope, Frank A. , Sargent, Daniel J. , Alberts, Steven R.

Clinical Cancer Research | July 17, 2015 | Volume: 21 | Issue: 23 | Pages: 5294-5304

10.1158/1078-0432.ccr-15-0527 | PMID 26187617 Get It

Abstract Purpose: To determine the frequency and prognostic association of molecular markers by anatomic tumor site in patients with stage III colon carcinomas. Experimental Design: In a randomized trial of adjuvant FOLFOX ± cetuximab, BRAFV600E and KRAS (exon 2) mutations and DNA mismatch repair (MMR) proteins were analyzed in tumors (N = 3,018) in relationship to tumor location, including subsite. Cox models were used to assess clinical outcome, including overall survival (OS). Results: KRAS codon 12 mutations were most frequent at the splenic flexure and cecum; codon 13 mutations were evenly distributed. BRAF mutation frequency sharply increased from transverse colon to cecum in parallel with deficient (d) MMR. Nonmutated BRAF and KRAS tumors progressively decreased from sigmoid to transverse (all P &lt; 0.0001). Significantly, poorer OS was found for mutant KRAS in distal [HR, 1.98; 95% confidence interval (CI), 1.49–2.63; P &lt; 0.0001] versus proximal (1.25; 95% CI, 0.97–1.60; P = 0.079) cancers. BRAF status and outcome were not significantly associated with tumor site. Proximal versus distal dMMR tumors had significantly better outcome. An interaction test was significant for tumor site by KRAS (Padjusted = 0.043) and MMR (Padjusted = 0.010) for OS. Significant prognostic differences for biomarkers by tumor site were maintained in the FOLFOX arm. Tumor site was independently prognostic with a stepwise improvement from cecum to sigmoid (OS: Padjusted = 0.001). Conclusions: Mutation in BRAF or KRAS codon 12 was enriched in proximal cancers whereas nonmutated BRAF/KRAS was increased in distal tumors. Significant differences in outcome for KRAS mutations and dMMR were found by tumor site, indicating that their interpretation should occur in the context of tumor location. Clin Cancer Res; 21(23); 5294–304. ©2015 AACR.
Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium
Stitzenberg, Karyn B., Schlichting, Jennifer A. , Hálfdánarson, Þorvarður R. , Juarez, Grelda Yazmin, Pendergast, Jane , Chrischilles, Elizabeth A. , Wallace, Robert B. , Charlton, Mary E, Pendergast, Jane F, Charlton, Mary E. , Lin, Chi H. , Halfdanarson, Thorvardur R , Chrischilles, Elizabeth A

Journal of Oncology Practice | July 17, 2015 | Volume: 11 | Issue: 4 | Pages: e476-e486

10.1200/jop.2015.004564 | PMID 26080831 Get It

Neoadjuvant treatment may result in better quality of life and functional status 1 year after diagnosis.